Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

novartis corporation (malaysia) sdn. bhd. - ofatumumab -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

novartis corporation (malaysia) sdn. bhd. - secukinumab -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

novartis corporation (malaysia) sdn. bhd. - secukinumab -

Singapore - English - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - basiliximab - injection, powder, for solution - 20 mg/vial - basiliximab 20 mg/vial

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - ciprofloxacin, quantity: 2 mg/ml; hydrocortisone, quantity: 10 mg/ml - ear drops, suspension - excipient ingredients: polysorbate 20; sodium acetate; glacial acetic acid; benzyl alcohol; hydrogenated soy phosphatidylcholine; sodium chloride; polyvinyl alcohol; purified water - for the treatment of acute bacterial otitis externa, caused by organisms susceptible to ciprofloxacin (see pharmacology), in adults and children aged 2 years and older.

Israel - English - Ministry of Health

novartis israel ltd - deferoxamine mesylate - powder for solution for inj/inf - deferoxamine mesylate 0.5 g/vial - deferoxamine - deferoxamine - treatment of chronic iron overload e.g.: transfusional haemosiderosis especially in thalassaemia major sideroblastic anaemia autoimmune haemolytic anaemia and other chronic anaemias idiopathic (primary) haemochromatosis in patients in whom concomitant disorders ( e.g. severe anaemia cardiac disease hypoproteinaemia) preclude phlebotomy iron overload associated with porphyria cutanea tarda. treatment of acute iron poisoning. treatment of chronic aluminium overload in patients with terminal renal failure (under maintenance dialysis) with: aluminium-related bone disease and/or dialysis encephalopathy and/or aluminium-related anaemia. diagnosis of iron overload.

Singapore - English - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - metformin hydrochloride; vildagliptin - tablet, film coated - 1000.0 mg - metformin hydrochloride 1000.0 mg; vildagliptin 50.0 mg

Singapore - English - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - metformin hydrochloride; vildagliptin - tablet, film coated - 850 mg - metformin hydrochloride 850 mg; vildagliptin 50 mg

Singapore - English - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - ranibizumab - injection, solution - 3mg - ranibizumab 2.3mg

Singapore - English - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - imatinib mesylate 119.5 mg eqv imatinib base - tablet, film coated - 100 mg - imatinib mesylate 119.5 mg eqv imatinib base 100 mg